Jennifer Lee is a board of directors, investor, and CEO of JLC Life Sciences consulting firm. She is an influential biotech executive, driving the transformation of innovative science into life-saving treatments for over two decades. Therapies she’s steered have culminated in $20 billion in value, seven global regulatory approvals, label changes, multiple inspections, and multi-million dollar exits.
Jennifer is a noted STEM advocate and contributes to the field through multiple board and advisory roles and publications.
Jennifer earned a bachelor’s degree in biochemistry from the University of Illinois at Chicago and a master’s in regulatory compliance from Northwestern University.
